Completed OBSERVATIONAL NCT04659512

Recurrent Neovascular Age-related Macular Degeneration After Therapy Suspension

Recurrent Neovascular Age-related Macular Degeneration After Discontinuation of VEGF Inhibitors Managed in a Treat and Extend Regimen

Sponsor: St. Erik Eye Hospital

Conditions Age-related Macular Degeneration

Updated 3 times since 2021 Last updated: Dec 9, 2020 Started: Oct 1, 2017 Primary completion: Feb 28, 2019 Completion: Jun 6, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04659512, this observational or N/A phase trial focuses on Age-related Macular Degeneration and remains completed. Sponsored by St. Erik Eye Hospital, it has been updated 3 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed

First recorded

Oct 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St. Erik Eye Hospital

Data source: St. Erik Eye Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stockholm, Sweden